Ro / Roman: a care perspective

One service, more than one preparation

Ro's ED menu includes Cialis, generic tadalafil and other tablet options, alongside compounded Ro Sparks and Daily Rise Gummies. Its page identifies the latter products as compounded and not FDA-approved. The menu is useful for understanding the range, but it is not a single treatment with one price or one evidence profile. [Ro ED menu]

This profile leaves the price at a selected-plan quote. The public page attaches conditions to its introductory promotion, including new-patient eligibility, a recurring plan and a minimum order. Confirm the initial amount, quantity and price after any promotion rather than treating an introductory offer as the enduring cost.

Be precise about a daily-use claim

A daily tadalafil tablet and a compounded gummy are different preparations even when their descriptions both emphasize less planning. The schedule guide explains prescription terminology. The preparation guide explains why a format change can introduce a separate approval and evidence question.

FDA distinguishes compounding from approved generics. The Cialis label's tadalafil-alone findings do not establish equivalent duration or benefit for Ro's combinations or other compounds. Ask the clinician what evidence applies to the actual product being proposed and what approved alternatives might meet the medical need. [FDA] [Cialis label]

Ask how the service handles the next question

NIDDK describes ED assessment as involving health, sexual and mental-health history, with examination or tests as appropriate. Ask how the online service handles a concern that needs more than the initial questionnaire, and who coordinates further care. A broad product menu does not establish that every concern fits an online prescribing route. [NIDDK]

Find out how to contact the treating team after receiving medication and how an order changes if the clinical plan changes. We have not tested Ro's patient pathway, fulfillment or cancellation process. The profile describes the public offer and the questions to resolve before relying on it.